MedPath

Autologous serum eardrops therapy for closing tympanic membrane perforations

Not Applicable
Conditions
internal otitis
Registration Number
JPRN-jRCTs031180262
Lead Sponsor
Kakehata Seiji
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Patients with tympanic membrane perforation

Exclusion Criteria

otitis media or otitis externa

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tympanic membrane closure rate
Secondary Outcome Measures
NameTimeMethod
Hearing improvement
© Copyright 2025. All Rights Reserved by MedPath